Oxymorphone Extended-Release Tablets and Pramlintide Subcutaneous
Determining the interaction of Oxymorphone Extended-Release Tablets and Pramlintide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: oxymorphone
Brand name: Opana, Opana ER, Numorphan HCl
Synonyms: Oxymorphone
Generic Name: pramlintide
Brand name: SymlinPen 120, SymlinPen 60, Symlin
Synonyms: Pramlintide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Oxymorphone Extended-Release Tablets-Pramosone
- Oxymorphone Extended-Release Tablets-Pramosone Cream
- Oxymorphone Extended-Release Tablets-Pramosone E Cream
- Oxymorphone Extended-Release Tablets-Pramosone Ointment
- Oxymorphone Extended-Release Tablets-Pramoxine and Hydrocortisone
- Oxymorphone Extended-Release Tablets-Pramoxine and Hydrocortisone Cream, Gel, and Ointment
- Pramlintide Subcutaneous-Oxymorphone Hydrochloride
- Pramlintide Subcutaneous-Oxymorphone Injection
- Pramlintide Subcutaneous-Oxymorphone Tablets
- Pramlintide Subcutaneous-Oxytocin
- Pramlintide Subcutaneous-Oxytocin Intravenous, Intramuscular
- Pramlintide Subcutaneous-Oxytrol